FABP4 as a therapeutic host target controlling SARS-CoV-2 infection. - Baazim H; Koyuncu E; Tuncman G; Burak MF; Merkel L; Bahour N; Karabulut ES; Lee GY; Hanifehnezhad A; Karagoz ZF; Földes K; Engin I; et al. (EMBO molecular medicine, 2025)